Study of heart device for Fontan procedure patients
Part of Genetic & congenital, Heart & circulation clinical trials.
This study follows patients who received an AFR device (a special catheter-based implant) to help improve blood flow in their heart after a Fontan surgery. Researchers want to understand how well the device works and its safety over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received an AFR device through the FDA's Expanded Access Program for a failing Fontan procedure (either the device was successfully placed or an attempt was made)
- You or your legal guardian must be willing to sign a consent form agreeing to participate
- You must understand the study's purpose and procedures before enrolling
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial gathers health data from a smartphone app to learn more about heart failure in people with a specific type of implanted heart device. The information will help doctors better understand how to treat and manage heart failure.
This study checks how well a specially designed aortic graft (a fenestrated device) works for people with specific types of enlarged or fast-growing aortic aneurysms. It may help confirm whether the device is safe and effective for preventing aneurysm problems.
This study follows people with chronic heart failure to see how well an implanted device (called the Occlutech AFR) works and whether it is safe over time. It may help doctors better understand who benefits and how to manage treatment safely.
This registry is a large, ongoing study that collects information about Abbott heart devices used in routine care. It helps doctors learn how well these devices work and how patients are doing over time, without changing your treatment plan.
This study tests a new heart implant called the Ventura IASD in people with weakened heart pumping (low ejection fraction). The goal is to see if it helps relieve symptoms and improve quality of life in patients with chronic heart failure.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
Hear when a new Univentricular Heart trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.